Repetitive Transcranial Magnetic Stimulation for Working Memory Deficits in Schizophrenia: A Systematic Review of Randomized Controlled Trials

• Published in: Neuropsychiatric disease and treatment Vol. 20; pp. 649 - 662
• Main Authors: Li, Li, Liu, Chaomeng, Pan, Weigang, Wang, Wen, Jin, Wenqing, Ren, Yanping, Ma, Xin
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2024; Dove; Dove Medical Press
• Subjects: Care and treatment; Health aspects; Magnetic brain stimulation; Medical research; Medicine, Experimental; Physiological aspects; randomized controlled trials; repetitive transcranial magnetic stimulation; Review; Schizophrenia; Short-term memory; Testing; working memory; China; schizophrenia; randomized controlled trials; working memory; review; repetitive transcranial magnetic stimulation
• ISSN: 1176-6328; 1178-2021; 1178-2021
• DOI: 10.2147/NDT.S450303

Working memory (WM) deficits are a significant component of neurocognitive impairment in individuals with schizophrenia (SCZ). Two previous meta-analyses, conducted on randomized controlled trials (RCTs), examined the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in addressing WM deficits in individuals diagnosed with SCZ. However, the conclusions drawn from these analyses were inconsistent. Additionally, the commonly used random effects (RE) models might underestimate statistical errors, attributing a significant portion of perceived heterogeneity between studies to variations in study quality. Therefore, this review utilized both RE and quality effects (QE) models to assess relevant RCTs comparing TMS with sham intervention in terms of clinical outcomes. A comprehensive literature search was conducted using PubMed and Scopus databases, resulting in the inclusion of 13 studies for data synthesis. Overall, regardless of whether the RE or QE model was used, eligible RCTs suggested that the TMS and sham groups exhibited comparable therapeutic effects after treatment. The current state of research regarding the use of rTMS as a treatment for WM deficits in patients with SCZ remains in its preliminary phase. Furthermore, concerning the mechanism of action, the activation of brain regions focused on the dorsolateral prefrontal cortex and alterations in gamma oscillations may hold significant relevance in the therapeutic application of rTMS for addressing WM impairments. Finally, we believe that the application of closed-loop neuromodulation may contribute to the optimization of rTMS for WM impairment in patients with SCZ.